{"product_id":"bpc-157-tb-500-blend","title":"BPC-157 + TB-500 Blend","description":"\u003cdiv class=\"prod-section\"\u003e\n    \u003cdiv class=\"prod-section-label\"\u003e\n        \u003ci class=\"ti ti-file-description\"\u003e\u003c\/i\u003eResearch Background\n    \u003c\/div\u003e\n\n    \u003cp class=\"prod-para\"\u003e\n        This precision-formulated dual-peptide blend brings together two of the most extensively studied tissue-repair compounds in research research. Each vial contains an equal 5mg\/5mg combination of BPC-157 and TB-500, lyophilized together in a single preparation for consistent, reproducible dosing.\n    \u003c\/p\u003e\n\n    \u003cp class=\"prod-para\"\u003e\n        BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid pentadecapeptide (sequence GEPPPGKPADDAGLV; CAS 137525-51-0; MW 1419.5 g\/mol) derived from a protein sequence found in human gastric juice. Its most remarkable property is exceptional stability in acidic, enzyme-rich environments — documented to remain intact in simulated gastric juice for over 24 hours. In research models, BPC-157 consistently activates the VEGF\/VEGFR2-Akt-eNOS angiogenic signaling axis and modulates the nitric oxide system, producing measurable proangiogenic and cytoprotective effects across gastrointestinal, musculoskeletal, tendon\/ligament, cardiovascular, and neurological injury models.\n    \u003c\/p\u003e\n\n    \u003cp class=\"prod-para\"\u003e\n        TB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ-NH2; CAS 885340-08-9) of thymosin beta-4, specifically reproducing the actin-binding domain. By modulating G-actin to F-actin polymerization balance, TB-500 enables directional cell migration toward injury sites — a fundamentally distinct mechanism from BPC-157's vascular priming. In research models, TB-500 has demonstrated cell migration promotion, reduced fibrotic scarring, and enhanced regeneration in cardiac, muscular, ocular, and dermal injury paradigms.\n    \u003c\/p\u003e\n\n    \u003cp class=\"prod-para\"\u003e\n        The scientific rationale is mechanistic complementarity: BPC-157 addresses vascular and inflammatory microenvironment — priming new vasculature, modulating nitric oxide, engaging angiogenic growth factors. TB-500 independently drives the cytoskeletal mechanics that enable repair cells to physically migrate toward and remodel damaged tissue. Together they address sequential phases of tissue repair in a single preparation.\n    \u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"prod-section\"\u003e\n    \u003cdiv class=\"prod-section-label\"\u003e\n        \u003ci class=\"ti ti-atom\"\u003e\u003c\/i\u003ePhysicochemical Data\n    \u003c\/div\u003e\n\n    \u003cdiv class=\"table-scroll\"\u003e\n        \u003ctable class=\"prod-table\"\u003e\n            \u003cthead\u003e\n                \u003ctr\u003e\n                    \u003cth\u003eCompound\u003c\/th\u003e\n                    \u003cth\u003eFormula\u003c\/th\u003e\n                    \u003cth\u003eMW\u003c\/th\u003e\n                    \u003cth\u003eCAS No.\u003c\/th\u003e\n                    \u003cth\u003eSequence \/ Structure\u003c\/th\u003e\n                    \u003cth\u003eReceptor \/ Target\u003c\/th\u003e\n                \u003c\/tr\u003e\n            \u003c\/thead\u003e\n\n            \u003ctbody\u003e\n                \u003ctr class=\"row-alt\"\u003e\n                    \u003ctd class=\"td-bold\"\u003eBPC-157\u003c\/td\u003e\n                    \u003ctd\u003eC62H98N16O22\u003c\/td\u003e\n                    \u003ctd\u003e1419.5 g\/mol\u003c\/td\u003e\n                    \u003ctd\u003e137525-51-0\u003c\/td\u003e\n                    \u003ctd\u003eGEPPPGKPADDAGLV\u003c\/td\u003e\n                    \u003ctd\u003e15-AA pentadecapeptide; NO\/VEGF modulator\u003c\/td\u003e\n                \u003c\/tr\u003e\n\n                \u003ctr\u003e\n                    \u003ctd class=\"td-bold\"\u003eTB-500 (Thymosin β4 fragment)\u003c\/td\u003e\n                    \u003ctd\u003eC38H68N10O14\u003c\/td\u003e\n                    \u003ctd\u003e~1019 g\/mol\u003c\/td\u003e\n                    \u003ctd\u003e885340-08-9\u003c\/td\u003e\n                    \u003ctd\u003eAc-LKKTETQ-NH2\u003c\/td\u003e\n                    \u003ctd\u003e7-AA actin-binding fragment; cell migration facilitator\u003c\/td\u003e\n                \u003c\/tr\u003e\n            \u003c\/tbody\u003e\n        \u003c\/table\u003e\n    \u003c\/div\u003e\n\u003c\/div\u003e","brand":"General Peptide","offers":[{"title":"1 Vial","offer_id":50856784560375,"sku":null,"price":108.0,"currency_code":"USD","in_stock":true},{"title":"3 Vials","offer_id":50856784593143,"sku":null,"price":292.0,"currency_code":"USD","in_stock":true},{"title":"5 Vials","offer_id":50856784625911,"sku":null,"price":432.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0934\/1485\/0807\/files\/Tissue-Repair_BPC-157-_-TB-500-Blend.jpg?v=1781177657","url":"https:\/\/generalpeptide.com\/products\/bpc-157-tb-500-blend","provider":"General Peptide","version":"1.0","type":"link"}